A61K33/02

Glutamate treatment of cardiovascular disorders

Compositions and methods for treating various cardiovascular disorders include targeted delivery of glutamate for impairing a targeted portion of the autonomic nervous system (ANS). Targeted delivery may be via direct injection into the targeted portion of the ANS or via vascular injection of magnetically-targetable nanoparticles.

Glutamate treatment of cardiovascular disorders

Compositions and methods for treating various cardiovascular disorders include targeted delivery of glutamate for impairing a targeted portion of the autonomic nervous system (ANS). Targeted delivery may be via direct injection into the targeted portion of the ANS or via vascular injection of magnetically-targetable nanoparticles.

COMBINED PREPARATIONS OF URINARY ACIDIFIERS AND CRYSTALLIZATION INHIBITORS AND APPLICATION THEREOF FOR THE TREATMENT OR PREVENTION OF PHOSPHATIC OR CALCIUM PHOSPHATE-INDUCED RENAL LITHIASIS

The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.

COMBINED PREPARATIONS OF URINARY ACIDIFIERS AND CRYSTALLIZATION INHIBITORS AND APPLICATION THEREOF FOR THE TREATMENT OR PREVENTION OF PHOSPHATIC OR CALCIUM PHOSPHATE-INDUCED RENAL LITHIASIS

The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.

COMBINED PREPARATIONS OF URINARY ACIDIFIERS AND CRYSTALLIZATION INHIBITORS AND APPLICATION THEREOF FOR THE TREATMENT OR PREVENTION OF PHOSPHATIC OR CALCIUM PHOSPHATE-INDUCED RENAL LITHIASIS

The present invention is related to the use of a separate, sequential or simultaneous combination of at least one urinary acidifier with at least one calcium phosphate crystallization inhibitor for urine acidification, and thus preventing the pH at which supersaturation of calcium phosphate is produced and consequently, renal lithiasis.

ORAL CARE COMPOSITION
20190201310 · 2019-07-04 · ·

An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.

ANTIMICROBIAL COMPOSITION
20190191700 · 2019-06-27 ·

An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.

ANTIMICROBIAL COMPOSITION
20190191700 · 2019-06-27 ·

An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.

Keratolytic composition with anti-allergic anti-inflammatory properties
10179148 · 2019-01-15 ·

A product with an enhanced medicinal and cosmetic composition with a specific utility of Psoriasis, Eczema and like skin disorders application is characterized by the fact that it comprises active agents and ingredients as vanilla extract, ammonium chloride, potassium chloride and quaternary ammonium compound having formulated at a specific pH value with other specially selected adjuvants and fillers.

Keratolytic composition with anti-allergic anti-inflammatory properties
10179148 · 2019-01-15 ·

A product with an enhanced medicinal and cosmetic composition with a specific utility of Psoriasis, Eczema and like skin disorders application is characterized by the fact that it comprises active agents and ingredients as vanilla extract, ammonium chloride, potassium chloride and quaternary ammonium compound having formulated at a specific pH value with other specially selected adjuvants and fillers.